How to switch from Lantus (insulin glargine) 20 units twice a day to NPH (Neutral Protamine Hagedorn) insulin twice a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Lantus 20 Units Twice Daily to NPH Twice Daily

When converting from Lantus (insulin glargine) 20 units twice daily (total 40 units/day) to NPH twice daily, use 80% of the total Lantus dose as your starting NPH dose, which equals 32 units total NPH per day, split as approximately 21 units before breakfast and 11 units before dinner (2/3 morning, 1/3 evening). 1

Conversion Algorithm

Step 1: Calculate Total NPH Dose

  • Current total daily Lantus dose: 40 units (20 units × 2)
  • Starting NPH dose: 32 units total (80% of 40 units) 1
  • This dose reduction accounts for the different pharmacokinetic profiles and helps prevent hypoglycemia during the transition 1

Step 2: Split the NPH Dose

  • Morning dose (before breakfast): 21 units (2/3 of total) 1
  • Evening dose (before dinner): 11 units (1/3 of total) 1
  • This distribution pattern aligns with typical insulin requirements and NPH's intermediate-acting profile 1

Step 3: Titration Protocol

  • Monitor fasting plasma glucose to assess adequacy of the evening NPH dose 1
  • Increase dose by 2 units every 3 days if glucose remains above target without hypoglycemia 1
  • For hypoglycemia: Determine the cause; if no clear reason exists, lower the corresponding dose by 10-20% 1

Critical Monitoring Parameters

Blood Glucose Targets

  • Check fasting glucose to adjust evening NPH dose 1
  • Check pre-dinner glucose to adjust morning NPH dose 1
  • Monitor for nocturnal hypoglycemia, which is more common with NPH than with Lantus 2, 3

Hypoglycemia Risk

  • NPH carries significantly higher risk of hypoglycemia compared to Lantus, particularly nocturnal episodes (26-59% increased risk) 3
  • The intermediate-acting profile of NPH creates a pronounced peak at 4-6 hours post-injection, unlike Lantus's flat profile 2, 3
  • Patients should be counseled about this increased risk and prescribed glucagon for emergencies 1

Important Clinical Considerations

Why This Conversion May Be Necessary

  • Cost considerations: NPH is significantly less expensive than Lantus 1
  • The American Diabetes Association guidelines acknowledge NPH as an appropriate basal insulin option when cost is a barrier 1

Common Pitfalls to Avoid

  • Do not convert unit-for-unit: Always use the 80% reduction to prevent hypoglycemia during transition 1
  • Do not give NPH at bedtime initially: The 2/3 morning, 1/3 evening split is preferred for twice-daily regimens 1
  • Do not delay dose adjustments: Reassess every 3 days and titrate based on glucose patterns 1

When to Reconsider This Switch

  • If the patient develops recurrent hypoglycemia despite dose adjustments, consider switching back to a basal analog 1
  • If the patient frequently forgets evening doses, morning-only long-acting basal insulin would be more appropriate 1
  • Patients with hypoglycemia unawareness are poor candidates for NPH due to its peaked action 1, 3

Additional Therapy Considerations

  • If the patient is not already on a GLP-1 receptor agonist, consider adding one to reduce insulin requirements and hypoglycemia risk 1
  • If prandial coverage is needed, NPH can be mixed with short- or rapid-acting insulin to reduce injection burden 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.